Cargando…
Neurons Derived From Patient-Specific Induced Pluripotent Stem Cells: a Promising Strategy Towards Developing Novel Pharmacotherapies for Autism Spectrum Disorders
Autores principales: | Mokhtari, Ryan, Lachman, Herbert M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972570/ https://www.ncbi.nlm.nih.gov/pubmed/27397513 http://dx.doi.org/10.1016/j.ebiom.2016.06.036 |
Ejemplares similares
-
Pharmacotherapy in autism spectrum disorders, including promising older drugs warranting trials
por: Hellings, Jessica
Publicado: (2023) -
Modeling the neuropsychiatric manifestations of Lowe syndrome using induced pluripotent stem cells: defective F-actin polymerization and WAVE-1 expression in neuronal cells
por: Barnes, Jesse, et al.
Publicado: (2018) -
Enriched expression of genes associated with autism spectrum disorders in human inhibitory neurons
por: Wang, Ping, et al.
Publicado: (2018) -
Advanced Pharmacotherapy Evidenced by Pathogenesis of Autism Spectrum Disorder
por: Lee, Yeon Jung, et al.
Publicado: (2014) -
Modeling Autism Spectrum Disorders with Induced Pluripotent Stem Cell-Derived Brain Organoids
por: Santos, John Lenon de Souza, et al.
Publicado: (2023)